Article by Dr Rashmi Raju PhD
For many MedTech and digital health innovators, international expansion feels like a natural next step. New markets promise larger patient populations, new customers, and new and larger opportunities for growth. However, the reality of entering global healthcare systems is rarely straightforward.
Each country brings its own regulatory framework, funding structures, procurement models and clinical priorities. What works in the UK may not translate in the United States, Europe, Singapore or India. Even when a product is clinically strong, commercial success depends on understanding who makes decisions, how reimbursement works, and what evidence local stakeholders expect. And this is where structured, specialist market access support becomes essential.
From Approval to Adoption – the Real Challenge
Adoption of an innovative medical technology can be one of the major challenges facing MedTech, diagnostic, digital health companies if the process is not fully understood. Many MedTech companies assume that the regulatory approval in different markets is the finish line, however it is really the starting point of the market access journey. Regulatory approval confirms that the innovative technology is safe and performs as intended. However, regulatory approval alone does not guarantee adoption. It is crucial to understand:
- How is care delivered in this market?
- How the technology fits into existing clinical pathways?
- Who will pay for the technology?
- What evidence is required for reimbursement?
- How to navigate fragmented decision-making and procurement structures?
- How will clinicians adopt and use the technology?
It is important to have a clear and strong market access strategy, even innovative technologies can struggle to secure pilots, funding, or long-term contracts. Therefore, successful market access requires an integrated approach that connects regulatory planning, health economics, clinical adoption, and commercial strategy.
Medilink’s Market Access team can help and support UK life sciences and MedTech businesses to answer these complex questions and navigate global healthcare systems. The team supports companies to “enter, scale and succeed in complex global healthcare systems” through regulatory expertise, commercial insight and international partnerships.
Medilink’s Market Access Services – Targeted Support Where It Matters
Medilink’s International Market Access services are structured around five core pillars, each addressing a critical element of global commercialisation.
- Market Segmentation and prioritisation
- Global Market Access Strategy
- International regulatory documentation, process and registration
- Reimbursement & Funding Pathways
- Market Access Programmes (MAPs) – Structured Acceleration into Key Markets
International expansion is rarely linear. Companies often need different types of support at different stages, from early market intelligence through to hands-on execution.
Medilink’s International Market Access team provides that continuity. Whether your business is exploring its first export opportunity or preparing for large-scale global rollout, the combination of market insight, regulatory understanding, reimbursement mapping and practical programmes ensures companies are better prepared for the realities of different healthcare systems.
The global MedTech opportunity has never been greater. But success depends on more than innovation. It depends on understanding markets, engaging the right stakeholders, and building credible pathways to funding and adoption.
Medilink help and support companies do exactly that, transforming promising technologies into products that are not only approved, but adopted, scaled and sustained across international healthcare systems.
Ready to Explore New Markets?
The International Market Access team can be contacted directly at [email protected] to discuss tailored support options for your technology.
Case Studies
Case Study 1 – Wellola
The Medilink International Market Access team supported Wellola with in-depth US market research with detailed information on healthcare setting, regulatory and reimbursement pathway for Portasana® platform.
Portasana® streamlines patient care by equipping individuals with the information needed for safer, quicker recovery and tailoring care for diverse needs, including language and learning barriers. It enhances communication between healthcare providers and patients, ensuring a well-informed treatment journey, while also improving operational efficiencies and cutting costs. The platform supports patient education and self-management, particularly for chronic conditions, and offers patient-led follow-up options, promoting autonomy. This innovation shifts care from hospitals to communities, personalising treatment pathways with its flexible, interoperable system.
Case Study 2 – Surgical Innovation
The Medilink International Market Access team support Surgical Innovation Ltd with market understanding of three target markets including Brazil, Mexico and Singapore with detailed information on medical device regulatory requirements and key medical device manufacturers in these markets for their YelloPort® technology.
Surgical Innovations are manufacturers of sustainable, high-performing surgical instrumentation. YelloPort® is an innovative hybrid technology designed to reduce the carbon footprint and plastic waste generated from Port Access Systems. The YelloPort® range is comprehensive in nature, with a wide range of Trocars and Cannulas available across the 3mm, 5mm, 10mm and 12mm sizes. These innovative solutions can help healthcare providers reduce their carbon footprint by ~76%, reduce clinical waste by ~ 85% and saving coast by ~42%.
The other Medilink specialist services include:
INNOVATION, COMMERCIALISATION & REGULATION
Unlock your innovation capabilities, understand the regulatory environment, and ensure your products are compliant.
EVENT & CONFERENCE MANAGEMENT
Lose the stress of event management and have Medilink provide services from email campaigns through to fully managed events.
DESIGN & MARKETING
Medilink UK has extensive design experience in the medtech and life sciences sector. For over 30 years, the organisation has supported manufacturers, research centres, and NHS organisations with tailored design, branding, and publishing services.
Additionally, Medilink UK provide a number of activities to support the UK life sciences community, including International Exhibitions and Support, Medilink UK National Awards, and various Sponsorship Opportunities.
Medilink UK is a unique UK life sciences network and specialist service provider. www.medilinkuk.com